NASDAQ:MLYS | EBITDA | Mineralys Therapeutics, Inc.

Complete source-backed ebitda history.

Available history
2023-03-31 to 2026-03-31
Data captured

Historical EBITDA

DateEBITDA
2026-03-31-$45.33M
2025-12-31-$38.27M
2025-03-31-$44.43M
2024-12-31-$51.75M
2024-03-31-$35.35M
2023-12-31-$27.71M
2023-03-31-$14.94M

Annual EBITDA

DateEBITDA
2025-12-31-$170.55M
2024-12-31-$192.36M
2023-12-31-$84.66M